FCAC vs. ATPC, EUDA, UPHL, ACHL, CRTX, MDAI, RVP, IPA, ACXP, and OMIC
Should you be buying Falcon Capital Acquisition stock or one of its competitors? The main competitors of Falcon Capital Acquisition include Agape ATP (ATPC), EUDA Health (EUDA), UpHealth (UPHL), Achilles Therapeutics (ACHL), Cortexyme (CRTX), Spectral AI (MDAI), Retractable Technologies (RVP), ImmunoPrecise Antibodies (IPA), Acurx Pharmaceuticals (ACXP), and Singular Genomics Systems (OMIC). These companies are all part of the "medical" sector.
Falcon Capital Acquisition (NASDAQ:FCAC) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, valuation, profitability, risk, dividends, earnings and analyst recommendations.
61.7% of Falcon Capital Acquisition shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Agape ATP has higher revenue and earnings than Falcon Capital Acquisition.
In the previous week, Falcon Capital Acquisition's average media sentiment score of 0.00 equaled Agape ATP'saverage media sentiment score.
Falcon Capital Acquisition and Agape ATP both received 0 outperform votes by MarketBeat users.
Falcon Capital Acquisition has a net margin of 0.00% compared to Agape ATP's net margin of -147.31%. Falcon Capital Acquisition's return on equity of 0.00% beat Agape ATP's return on equity.
Summary
Falcon Capital Acquisition beats Agape ATP on 4 of the 6 factors compared between the two stocks.
Get Falcon Capital Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for FCAC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FCAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Falcon Capital Acquisition Competitors List
Related Companies and Tools
